Ivermectin Dosing for 48 kg Adult Male
For a 48 kg adult male, administer 3 tablets of ivermectin 3 mg (total 9 mg) as a single oral dose on an empty stomach with water. 1
Indication-Specific Dosing
The appropriate ivermectin dose depends on the specific parasitic infection being treated:
Strongyloidiasis
- Dose: 200 mcg/kg as a single oral dose 1
- For 48 kg patient: 9.6 mg (approximately 3 tablets of 3 mg each)
- According to FDA dosing guidelines, patients weighing 36-50 kg receive 3 tablets 1
- Take on empty stomach with water to optimize absorption 1
- Follow-up stool examinations should verify eradication; additional doses generally not necessary 1
Onchocerciasis
- Dose: 150 mcg/kg as a single oral dose 1
- For 48 kg patient: 7.2 mg (approximately 2-3 tablets)
- FDA guidelines specify patients 45-64 kg receive 3 tablets 1
- Retreatment may be considered at intervals as short as 3 months for individual patients 1
- In mass distribution campaigns, 12-month intervals are most common 1
Loiasis (Alternative Treatment)
- Dose range: 150-200 mcg/kg 2
- Most commonly given as single dose, though some guidelines recommend daily dosing for up to 10 days in endemic settings 2
- Critical safety consideration: Microfilarial load must be assessed before treatment
Key Administration Points
Timing and Food Interactions:
- Always administer on empty stomach with water 1
- High-fat meals increase bioavailability approximately 2.5-fold, which may increase adverse effects 1
Pharmacokinetics:
- Plasma half-life: approximately 18 hours 1
- Peak concentrations occur approximately 4 hours post-dose 1
- Metabolized primarily by CYP3A4 in the liver 1
Safety Considerations
Common Pitfalls to Avoid:
- Never use in Loa loa co-infection without careful microfilarial assessment - risk of severe encephalopathy 2
- Check for concomitant onchocerciasis in loiasis patients, as treatment algorithms differ 2
- Avoid in patients with severe liver disease 3
- Contraindicated in pregnancy and breastfeeding 3
Drug Interactions:
- Monitor patients on CYP3A4 inhibitors or inducers 1
- Avoid concurrent use with other drugs that may lower seizure threshold
Weight Threshold:
- Minimum weight for treatment: 48 kg 3
- Your patient is at the exact minimum threshold - ensure accurate weight measurement
Clinical Monitoring
After treatment, monitor for:
- Adverse events (headache most common across all indications) 3
- Treatment efficacy through appropriate follow-up testing (stool exams for strongyloidiasis, skin snips for onchocerciasis) 1
- In loiasis: close observation for neurological symptoms if microfilarial load was elevated 2
The ivermectin dose calculation is straightforward for this 48 kg patient, falling precisely at the lower weight threshold in FDA dosing tables, making 3 tablets (9 mg total) the definitive dose for strongyloidiasis and the appropriate starting point for other indications 1.